All Stories

  1. Circulating Meteorin-like Levels in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis
  2. Association of Leptin Gene Polymorphisms with Rheumatoid Arthritis in a Chinese Population
  3. Associations of extreme temperatures with hospitalizations and post-discharge deaths for stroke: What is the role of pre-existing hyperlipidemia?
  4. Circulating adiponectin levels and systemic lupus erythematosus: a two-sample Mendelian randomization study
  5. Identification of new susceptibility loci associated with rheumatoid arthritis
  6. Low ambient temperature increases hospital re-admissions for systemic lupus erythematosus in humid subtropical region: a time series study
  7. Prevalence and influential factors of thrombocytopaenia in systemic lupus erythematosus patients: a retrospective analysis of 3140 cases in a Chinese population
  8. Natural Products: Experimental Efficient Agents for Inflammatory Bowel Disease Therapy
  9. Association of Melatonin Pathway Gene’s Single-Nucleotide Polymorphisms with Systemic Lupus Erythematosus in a Chinese Population
  10. Effect of air pollution on hospital admissions for systemic lupus erythematosus in Bengbu, China: a time series study
  11. Therapeutic potential of aryl hydrocarbon receptor in autoimmunity
  12. Circulating pentraxin-3 levels in patients with systemic lupus erythematosus: a meta-analysis
  13. Seasonality and global public interest in psoriasis: an infodemiology study
  14. Decreased Expression of Semaphorin 3A and Semaphorin 7A Levels and Its Association with Systemic Lupus Erythematosus
  15. Plasma galectin‐3 levels do not differ in systemic lupus erythematosus patients
  16. Correction: Leveraging Google Trends to investigate the global public interest in rheumatoid arthritis
  17. Differential Plasma Expression Profiles of Long Non-Coding RNAs Reveal Potential Biomarkers for Systemic Lupus Erythematosus
  18. Semaphorin-3A, semaphorin-7A gene single nucleotide polymorphisms, and systemic lupus erythematosus susceptibility
  19. Association between Interleukin 35 Gene Single Nucleotide Polymorphisms and Systemic Lupus Erythematosus in a Chinese Han Population
  20. Leveraging Google Trends to investigate the global public interest in rheumatoid arthritis
  21. Differentially expressed circular RNAs in systemic lupus erythematosus and their clinical significance
  22. Emerging role of lncRNAs in systemic lupus erythematosus
  23. Circulating Levels of Osteoprotegerin, Osteocalcin and Osteopontin in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
  24. Circulating Matrix Metalloproteinase-9 Levels in Patients with Systemic Lupus Erythematosus: A Meta-analysis
  25. The expression levels of long noncoding RNAs lnc0640 and lnc5150 and its gene single-nucleotide polymorphisms in rheumatoid arthritis patients
  26. RNAi Silencing of HIF-1α Ameliorates Lupus Development in MRL/lpr Mice
  27. Subclinical Atherosclerosis in Patients With Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis
  28. Association of single nucleotide polymorphisms in resistin gene with rheumatoid arthritis in a Chinese population
  29. Postpartum depressive mood (PDM) among Chinese women: a meta-analysis
  30. NLRP3: A promising therapeutic target for autoimmune diseases
  31. Associations of HSP90AA2 gene polymorphisms with disease susceptibility, glucocorticoids efficacy and health-related quality of life in Chinese systemic lupus erythematosus patients
  32. Lack of association between mean platelet volume and disease activity in systemic lupus erythematosus patients: a systematic review and meta-analysis
  33. Circular RNA expression profile and potential function of hsa_circ_0045272 in systemic lupus erythematosus
  34. Meta-analysis of GWAS on both Chinese and European populations identifies GPR173 as a novel X chromosome susceptibility gene for SLE
  35. Emerging role of semaphorin-3A in autoimmune diseases
  36. Identification ofST3AGL4,MFHAS1, CSNK2A2andCD226as loci associated with systemic lupus erythematosus (SLE) and evaluation of SLE genetics in drug repositioning
  37. Features associated with pulmonary arterial hypertension in Chinese hospitalized systemic lupus erythematosus patients
  38. Association ofinterleukin-10gene single nucleotide polymorphisms with rheumatoid arthritis in a Chinese population
  39. Association of interleukin-10 gene single nucleotide polymorphisms with susceptibility to systemic lupus erythematosus in a Chinese population
  40. Potential link between m 6 A modification and systemic lupus erythematosus
  41. Prevalence of pulmonary hypertension in systemic lupus erythematosus: a meta-analysis
  42. Coagulation cascade and complement system in systemic lupus erythematosus
  43. Translation of noncoding RNAs: Focus on lncRNAs, pri-miRNAs, and circRNAs
  44. Elevated seroprevalence of Toxoplasma gondii in AIDS/HIV patients: A meta-analysis
  45. Association between HLA-DQB1 polymorphisms and pemphigus vulgaris: A meta-analysis
  46. Clinical and serological associations of anti-ribosomal P0 protein antibodies in systemic lupus erythematosus
  47. Association of long noncoding RNAs expression levels and their gene polymorphisms with systemic lupus erythematosus
  48. Comparison of plasma/serum levels of procalcitonin between infection and febrile disease flare in patients with systemic lupus erythematosus: a meta-analysis
  49. Comprehensive long non-coding RNA expression profiling reveals their potential roles in systemic lupus erythematosus
  50. Association between serum/plasma adiponectin levels and immune-mediated diseases: a meta-analysis
  51. Circulating osteoprotegerin levels are elevated in rheumatoid arthritis: a systematic review and meta-analysis
  52. Altered microRNAs expression in T cells of patients with SLE involved in the lack of vitamin D
  53. Increased Pulse Wave Velocity in Systemic Lupus Erythematosus: A Meta-Analysis
  54. Hypoxia-inducible factor-1α: a promising therapeutic target for autoimmune diseases
  55. miR-210 expression in PBMCs from patients with systemic lupus erythematosus and rheumatoid arthritis
  56. Associated Variables of Myositis in Systemic Lupus Erythematosus: A Cross-Sectional Study
  57. Effect of Short Message Service on Management of Pulmonary Tuberculosis Patients in Anhui Province, China: A Prospective, Randomized, Controlled Study
  58. Association of HLA-DQB1 polymorphisms with rheumatoid arthritis: a meta-analysis
  59. Competitive endogenous RNA network: potential implication for systemic lupus erythematosus
  60. Association of leptin and leptin receptor gene polymorphisms with systemic lupus erythematosus in a Chinese population
  61. Identification of long non-coding RNAs GAS5, linc0597 and lnc-DC in plasma as novel biomarkers for systemic lupus erythematosus
  62. Meta-analysis of associations between XRCC1 gene polymorphisms and susceptibility to systemic lupus erythematosus and rheumatoid arthritis
  63. Safety of measles-containing vaccines in post-marketing surveillance in Anhui, China
  64. Intratumoral and peritumoral expression of CD68 and CD206 in hepatocellular carcinoma and their prognostic value
  65. The prevalence and risk factors for serositis in patients with systemic lupus erythematosus: a cross-sectional study
  66. Elevated plasma midkine and pleiotrophin levels in patients with systemic lupus erythematosus
  67. Decreased flow-mediated dilatation in patients with rheumatoid arthritis: a meta-analysis
  68. Genetic variant of IL-10RA and susceptibility to rheumatoid arthritis in a Chinese population
  69. Associations between TNFAIP3 gene polymorphisms and systemic lupus erythematosus risk: an updated meta-analysis
  70. Increased plasma/serum levels of prolactin in systemic lupus erythematosus: a systematic review and meta-analysis
  71. Interleukin-35: a Potential Therapeutic Agent for Autoimmune Diseases
  72. Effects of Disease Activity and Inflammatory Response on Hypercoagulability in Patients with Systemic Lupus Erythematosus
  73. A meta-analysis of the relationship between MYO9B gene polymorphisms and susceptibility to Crohn’s disease and ulcerative colitis
  74. Plasma levels of adipokines in systemic lupus erythematosus patients
  75. Evidence of epistatic interaction betweenDPP4andCCR6in patients with rheumatoid arthritis
  76. Association between IRAK1 rs3027898 and miRNA-499 rs3746444 polymorphisms and rheumatoid arthritis
  77. Probiotic bacteria: a viable adjuvant therapy for relieving symptoms of rheumatoid arthritis
  78. Circular RNAs and systemic lupus erythematosus
  79. Plasma melatonin levels do not differ in SLE patients
  80. MicroRNA-210 and its theranostic potential
  81. Emerging role of adipokines in systemic lupus erythematosus
  82. Relationship between the IL12B (rs3212227) gene polymorphism and susceptibility to multiple autoimmune diseases: A meta-analysis
  83. TCR-CD3ζ gene polymorphisms and expression profile in rheumatoid arthritis
  84. Association between rs6887695 and 3′-untranslated region polymorphisms within theinterleukin-12Bgene and susceptibility to autoimmune diseases in Asian and European population: A meta-analysis
  85. Genetic Polymorphism (rs329498) in the Pellino-1 Gene as Possible Predisposal Factor for Systemic Lupus Erythematosus in a Chinese Population
  86. Single nucleotide polymorphisms of HSP90AA1 gene influence response of SLE patients to glucocorticoids treatment
  87. Evidence for genetic association of TBX21 and IFNG with systemic lupus erythematosus in a Chinese Han population
  88. Subclinical atherosclerosis in patients with systemic lupus erythematosus: A systemic review and meta-analysis
  89. Complement C4 induces regulatory T cells differentiation through dendritic cell in systemic lupus erythematosus
  90. Increased carotid intima-media thickness in rheumatoid arthritis: an update meta-analysis
  91. Therapeutic potential of IL-15 in rheumatoid arthritis
  92. Gene-Based Meta-Analysis of Genome-Wide Association Study Data Identifies Independent Single-Nucleotide Polymorphisms inANXA6as Being Associated With Systemic Lupus Erythematosus in Asian Populations
  93. Association Study of Matrix Metalloproteinases Gene Polymorphisms with Susceptibility to Rheumatoid Arthritis: A Meta-Analysis
  94. Plasma/Serum Leptin Levels in Patients with Systemic Lupus Erythematosus: A Meta-analysis
  95. Emerging role of long noncoding RNAs in autoimmune diseases
  96. Glucocorticoid receptor genetic polymorphisms is associated with improvement of health-related quality of life in Chinese population with systemic lupus erythematosus
  97. Association of UBASH3A gene polymorphisms and systemic lupus erythematosus in a Chinese population
  98. Increased carotid intima–media thickness (CIMT) levels in patients with type 1 diabetes mellitus (T1DM): A meta-analysis
  99. Epidemiological characteristics and influential factors of hand, foot and mouth disease (HFMD) reinfection in children in Anhui province
  100. Serum resistin levels in patients with rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis
  101. Associations Between PADI4 Gene Polymorphisms and Rheumatoid Arthritis: An Updated Meta-analysis
  102. Association of lymphotoxin alpha polymorphism with systemic lupus erythematosus and rheumatoid arthritis: a meta-analysis
  103. Decreased UBASH3A mRNA Expression Levels in Peripheral Blood Mononuclear Cells from Patients with Systemic Lupus Erythematosus
  104. A literature review on the patients with autoimmune diseases following vaccination against infections
  105. Genome-wide search followed by replication reveals genetic interaction ofCD80andALOX5APassociated with systemic lupus erythematosus in Asian populations
  106. Meta-analysis of two Chinese populations identifies an autoimmune disease risk allele in 22q11.21 as associated with systemic lupus erythematosus
  107. IL-17A-producing CD8+T cells as therapeutic targets in autoimmunity
  108. Association between CARD8 rs2043211 Polymorphism and Inflammatory Bowel Disease: A Meta-Analysis
  109. microRNAs function in CD8+ T cell biology
  110. Long noncoding RNAs: Novel insights into gastric cancer
  111. Novel insights into Tim-4 function in autoimmune diseases
  112. The decreased frequency of SIGIRR-positive CD4+ T cells in peripheral blood of patients with SLE and its correlation with disease activity
  113. Tc17 Cells in Immunity and Systemic Autoimmunity
  114. Meta-analysis of GWAS on two Chinese populations followed by replication identifies novel genetic variants on the X chromosome associated with systemic lupus erythematosus
  115. Association of IL-21 polymorphisms (rs907715, rs2221903) with susceptibility to multiple autoimmune diseases: A meta-analysis
  116. Association of FCGR2A-R/H131 polymorphism with susceptibility to systemic lupus erythematosus among Asian population: a meta-analysis of 20 studies
  117. Decreased Flow-Mediated Dilatation in Patients with Systemic Lupus Erythematosus: a Meta-analysis
  118. The Risk Factors of Avascular Necrosis in Patients with Systemic Lupus Erythematosus: a Meta-analysis
  119. Therapeutic potential of STAT4 in autoimmunity
  120. Emerging Role of SIGIRR rs7396562(T/G) Polymorphism in Systemic Lupus Erythematosus in a Chinese Population
  121. Therapeutic Potential of HO-1 in Autoimmune Diseases
  122. Association study ofinterleukin-19 rs2243188polymorphism with systemic lupus erythematosus in a Chinese population
  123. CTLA-4 CT60(rs3087243) polymorphism and autoimmune thyroid diseases susceptibility: a comprehensive meta-analysis
  124. SOCS signaling in autoimmune diseases: Molecular mechanisms and therapeutic implications
  125. Therapeutic potential of tyrosine kinase 2 in autoimmunity
  126. Relationship between the IL-4 gene promoter -590C/T (rs2243250) polymorphism and susceptibility to autoimmune diseases: a meta-analysis
  127. Association of CTLA-4 variants with susceptibility to inflammatory bowel disease: A meta-analysis
  128. Associations between TNF gene polymorphisms (−308 A/G, −238 A/G, −1031 C/T and −857 T/C) and genetic susceptibility to T1D: a meta-analysis
  129. Increased leptin levels in patients with rheumatoid arthritis: a meta-analysis
  130. Association of signaling transducers and activators of transcription 1 and systemic lupus erythematosus
  131. Lung, liver, prostate, bladder malignancies risk in systemic lupus erythematosus: evidence from a meta-analysis
  132. Serum levels of cytokines in systemic lupus erythematosus
  133. New evidence for roles of growth arrest-specific protein 6 (Gas6) in systemic lupus erythematosus
  134. Targeting T-helper 9 cells and interleukin-9 in autoimmune diseases
  135. Association of XPC Gene Polymorphisms with Susceptibility to Prostate Cancer: Evidence from 3,936 Subjects
  136. Genetic interaction between genes involved in NF-κB signaling pathway in systemic lupus erythematosus
  137. Meta-analysis of association between cytokine gene polymorphisms and Behcet's disease risk
  138. Prevalence of systemic lupus erythematosus and risk factors in rural areas of Anhui Province
  139. Interleukin-7 Receptor Single Nucleotide Polymorphism rs6897932 (C/T) and the Susceptibility to Systemic Lupus Erythematosus
  140. Lack of association between the polymorphisms of hypoxia-inducible factor 1A (HIF1A) gene and SLE susceptibility in a Chinese population
  141. Expression of Ets-1 and FOXP3 mRNA in CD4+CD25+ T regulatory cells from patients with systemic lupus erythematosus
  142. Association study of glucocorticoid receptor genetic polymorphisms with efficacy of glucocorticoids in systemic lupus erythematosus: A prospective cohort study
  143. Associations of Interleukin-4 Receptor Gene Polymorphisms (Q551R, I50V) with Rheumatoid Arthritis: Evidence from a Meta-Analysis
  144. Lack of association of IL-6 polymorphism with rheumatoid arthritis/type 1 diabetes: A meta-analysis
  145. Three SNPs in chromosome 11q23.3 are independently associated with systemic lupus erythematosus in Asians
  146. The association of IL1α and IL1β polymorphisms with susceptibility to systemic lupus erythematosus: A meta-analysis
  147. Identification of MFG-E8 as a novel therapeutic target for diseases
  148. Perspectives of the relationship between IL-7 and autoimmune diseases
  149. Impact of Environmental Factors on Efficacy of Glucocorticoids in Chinese Population with Systemic Lupus Erythematosus
  150. IL-10RB rs2834167 (A/G) Polymorphism Is Associated with the Susceptibility to Systemic Lupus Erythematosus: Evidence from a Study in Chinese Han Population
  151. Lack of association between IL-23R gene polymorphisms and systemic lupus erythematosus in a Chinese population
  152. A bibliometric study of literature on SLE research in PubMed (2002–2011)
  153. Association of IFIH1 rs1990760 polymorphism with susceptibility to autoimmune diseases: A meta-analysis
  154. Decreased ITGAM and FcγRIIIA mRNA expression levels in peripheral blood mononuclear cells from patients with systemic lupus erythematosus
  155. Role of interleukin-10 and interleukin-10 receptor in systemic lupus erythematosus
  156. Association between leptin and systemic lupus erythematosus
  157. IL-32 with potential insights into rheumatoid arthritis
  158. Association of the −1082G/A polymorphism in the interleukin-10 gene with systemic lupus erythematosus: A meta-analysis
  159. Therapeutic potential of SIGIRR in systemic lupus erythematosus
  160. D18S880 Microsatellite Polymorphism of Carnosinase Gene and Diabetic Nephropathy: A Meta-Analysis
  161. Decreased serum level of IL-21 in new-onset systemic lupus erythematosus patients
  162. Sex-specific differences in the relationship between the single-nucleotide polymorphism rs2298804 ofFCER1Aand the susceptibility to systemic lupus erythematosus in a Chinese Han population
  163. MicroRNA-21 with therapeutic potential in autoimmune diseases
  164. Association study of TRAF1/C5 polymorphism (rs10818488) with susceptibility to rheumatoid arthritis and systemic lupus erythematosus: A meta-analysis
  165. Association of P2X7R gene polymorphisms with systemic lupus erythematosus in a Chinese population
  166. Emerging role of interleukin-22 in autoimmune diseases
  167. CTLA-4 -1722T/C Polymorphism and Systemic Lupus Erythematosus Susceptibility: A Meta-analysis Involving Ten Separate Studies
  168. Meta-analysis Followed by Replication Identifies Loci in or near CDKN1B, TET3, CD80, DRAM1, and ARID5B as Associated with Systemic Lupus Erythematosus in Asians
  169. Interferon regulatory factor 5 and autoimmune lupus
  170. Association of interleukin-18 and systemic lupus erythematosus
  171. Gene–Gene and Gene-Sex Epistatic Interactions of MiR146a, IRF5, IKZF1, ETS1 and IL21 in Systemic Lupus Erythematosus
  172. IL-33
  173. Lack of association of TLR4 polymorphisms with susceptibility to rheumatoid arthritis and ankylosing spondylitis: A meta-analysis
  174. Association of the interleukin-10 gene polymorphism (–1082A/G) with systemic lupus erythematosus: a meta-analysis
  175. MicroRNA-101, mitogen-activated protein kinases and mitogen-activated protein kinases phosphatase-1 in systemic lupus erythematosus
  176. Association Study of IFIH1 rs1990760 Polymorphism with Systemic Lupus Erythematosus in a Chinese Population
  177. Association of RANTES and MBL gene polymorphisms with systemic lupus erythematosus: a meta-analysis
  178. Expression profiles of Th17 pathway related genes in human systemic lupus erythematosus
  179. Targeting IRF4 in autoimmune diseases
  180. Association of AFF1 rs340630 and AFF3 rs10865035 polymorphisms with systemic lupus erythematosus in a Chinese population
  181. Association of TNFSF4 polymorphisms with systemic lupus erythematosus: a meta-analysis
  182. Association of Interleukin 1α Promoter Polymorphism (–889C/T) with Susceptibility to Systemic Sclerosis
  183. Matrix Metalloproteinases: A Review of Their Structure and Role in Systemic Sclerosis
  184. A Single Nucleotide Polymorphism of IL-21 Gene is Associated with Systemic Lupus Erythematosus in a Chinese Population
  185. Association of c-Jun Gene Polymorphism with Susceptibility to Systemic Lupus Erythematosus in a Chinese Population
  186. Prognostic value of matrix metalloproteinase 9 expression in patients with non-small cell lung cancer
  187. Association of FAS gene polymorphisms with systemic lupus erythematosus: A case-control study and meta-analysis
  188. Association of interleukin 23 receptor gene polymorphisms (rs10489629, rs7517847) with rheumatoid arthritis in European population: a meta-analysis
  189. IRF7, a functional factor associates with systemic lupus erythematosus
  190. APRIL in systemic lupus erythematosus: Essential or dispensable? Comment on the article by Jacob et al
  191. Association of MicroRNA-146a with Autoimmune Diseases
  192. The TLR7 7926A>G polymorphism is associated with susceptibility to systemic lupus erythematosus
  193. New evidence for the role of proteasome inhibitors in systemic lupus erythematosus: Comment on the article by Ichikawa et al
  194. New evidence for a role ofMICAin the pathogenesis of systemic lupus erythematosus: Comment on the article by Yoshida et al
  195. Association of PTPN22 C1858T Polymorphism and Type 1 Diabetes: A Meta-analysis
  196. Role of CREM in systemic lupus erythematosus
  197. The therapeutic potential of the targeted autoreactive B lymphocytes by rituximab in SLE
  198. Association of the interleukin-10 1082G/A, 819C/T and 3575T/A gene polymorphisms with systemic sclerosis: a meta-analysis
  199. New evidence for roles of antinucleosome antibodies in systemic lupus erythematosus
  200. A meta-analysis of the association between cytokine gene polymorphisms and systemic sclerosis
  201. Treatment adherence among sputum smear-positive pulmonary tuberculosis patients in mountainous areas in China
  202. Interleukin-18: Friend or Foe for Systemic Sclerosis?
  203. Association of RIP2 gene polymorphisms and systemic lupus erythematosus in a Chinese population
  204. Association of CD247 with systemic lupus erythematosus in Asian populations
  205. Targeting IL-6 promoter polymorphism −174G/C should be dependent on ethnicity
  206. Expression of human tumor necrosis factor-like weak inducer of apoptosis in patients with systemic lupus erythematosus
  207. Prevalence and correlates of suicidal ideation in SLE inpatients: Chinese experience
  208. Seasonal distribution of systemic lupus erythematosus activity and its correlation with climate factors
  209. Lack of association of interleukin-18 gene promoter −607 A/C polymorphism with susceptibility to autoimmune diseases: a meta-analysis
  210. Role of microRNA-155 in autoimmunity
  211. The dual nature of Ets-1: Focus to the pathogenesis of systemic lupus erythematosus
  212. The association between GSTM1 polymorphism and gastric cancer risk: a meta-analysis
  213. Is transforming growth factor β always necessary for generation of pathogenic Th17 cells in autoimmune disease? Comment on the article by Morita et al
  214. Association of TNF-α promoter-308 A/G polymorphism with susceptibility to systemic lupus erythematosus: a meta-analysis
  215. Expressions of IL-22 in circulating CD4+/CD8+ T cells and their correlation with disease activity in SLE patients
  216. Expression of inducible co-stimulator on peripheral blood T lymphocytes in patients with lupus nephritis
  217. Association of interleukin-6 promoter polymorphism (−174 G/C) with systemic lupus erythematosus
  218. Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention
  219. Polymorphisms of the TIM-1 and TIM-3 genes are not associated with systemic lupus erythematosus in a Chinese population
  220. Ets-1: a new player in the pathogenesis of systemic lupus erythematosus?
  221. Association of ITGAM polymorphism with systemic lupus erythematosus: a meta-analysis
  222. Osteopontin receptor-dependent regulation of Th1 and Th17 responses in autoimmune diseases: Comment on the article by Chen et al
  223. Increased serum RANTES in patients with systemic lupus erythematosus
  224. Role and therapeutic potential of Glycodelin A in systemic lupus erythematosus
  225. Saikosaponins: a potential treatment option for systemic lupus erythematosus
  226. Interleukin-21 as a potential therapeutic target for systemic lupus erythematosus
  227. IL-19, IL-20 and IL-24: potential therapeutic targets for autoimmune diseases
  228. ELF1 is associated with systemic lupus erythematosus in Asian populations
  229. Epidemiological investigation of scarlet fever in Hefei City, China, from 2004 to 2008
  230. Prevalence and clinical significance of 15 autoantibodies in patients with new-onset systemic lupus erythematosus
  231. Elevated serum levels of MMP-2, MMP-3, and MMP-13 in Chinese patients with systemic lupus erythematosus
  232. Cholecystokinin octapeptide (CCK-8): friend or foe for rheumatoid arthritis?
  233. The role of IL-23/IL-17 axis in the etiopathogenesis of Behçet's disease
  234. Tumor necrosis factor-α-308A allele may have a protective effect for chronic hepatitis B virus infection in Mongoloid populations
  235. 1,25-Dihydroxyvitamin D3 may be insufficient to prevent corticosteroid-induced osteoporosis in patients with early rheumatoid arthritis: Comment on the article by Colin et al
  236. Anti-Ro antibody and clinical manifestations: lessons from systemic lupus erythematosus in the elderly
  237. Family Factors Associated With Suicide Attempts Among Chinese Adolescent Students: A National Cross-Sectional Survey
  238. BMI, disease activity, and health-related quality-of-life in systemic lupus erythematosus
  239. Comment on “Human Pregnancy Up-regulates Tim-3 in Innate Immune Cells for Systemic Immunity”
  240. IL-23: A Promising Therapeutic Target for Systemic Lupus Erythematosus
  241. Serum IL-17 level in systemic lupus erythematosus patients
  242. TWEAK as a target for therapy in systemic lupus erythematosus
  243. Therapeutic potential of IL-27 in systemic lupus erythematosus
  244. Juvenile and adult-onset systemic lupus erythematosus: an ethnicity-based comparison
  245. Lack of association of FcγRIIIb polymorphisms with systemic lupus erythematosus: a meta-analysis
  246. A meta-analysis of the association of STAT4 polymorphism with systemic lupus erythematosus
  247. Genome-Wide Association Study in Asian Populations Identifies Variants in ETS1 and WDFY4 Associated with Systemic Lupus Erythematosus
  248. Role of the Fcγ receptor IIIA-V/F158 polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis
  249. Protective role of moderate alcohol drinking in systemic lupus erythematosus
  250. Assay of T- and NK-cell subsets and the expression of NKG2A and NKG2D in patients with new-onset systemic lupus erythematosus
  251. TGFBR1*6A/9A polymorphism and cancer risk: a meta-analysis of 13,662 cases and 14,147 controls
  252. Polymorphism of IL-8 in 251 Allele and Gastric Cancer Susceptibility: A Meta-Analysis
  253. TIM-3 as a new therapeutic target in systemic lupus erythematosus
  254. Gender and age influence on clinical and laboratory features in Chinese patients with systemic lupus erythematosus: 1,790 cases
  255. Treatment outcome of radiotherapy alone versus radiochemotherapy in early stage nasal natural killer/T-cell lymphoma
  256. Study on clinical features and complications with systemic lupus erythematosus (SLE) activity in Chinese Han population
  257. Tuberculosis in systemic lupus erythematosus in Chinese patients
  258. Paclitaxel: Friend or Foe for Systemic Lupus Erythematosus?
  259. Season of birth: A potential influential factor for quality of life
  260. Increased serum interleukin 17 in patients with systemic lupus erythematosus
  261. Anti-α-actinin antibodies in relation to new-onset systemic lupus erythematosus and lupus nephritis
  262. Decreased serum IL-22 levels in patients with systemic lupus erythematosus
  263. High Mobility Group Box 1: a potential therapeutic target for systemic lupus erythematosus
  264. FAS −1,377 G/A polymorphism is associated with cancer susceptibility: evidence from 10,564 cases and 12,075 controls
  265. Clinical and serological correlates of anti-Sm autoantibodies in Chinese patients with systemic lupus erythematosus: 1,584 cases
  266. Association study of a single nucleotide polymorphism in the exon 2 region of toll-like receptor 9 (TLR9) gene with susceptibility to systemic lupus erythematosus among Chinese
  267. Susceptibility to systemic lupus erythematosus may be related to gene dosage effect of the X chromosome
  268. Fas expression on peripheral blood lymphocytes in systemic lupus erythematosus: relation to the organ damage and lymphocytes apoptosis
  269. Influence of social support on health-related quality of life in patients with systemic lupus erythematosus
  270. Metabolic syndrome: A potential culprit for Alzheimer’s disease?
  271. Moderate alcohol drinking might be protective for systemic lupus erythematosus: a systematic review and meta-analysis
  272. Radix Astragali: A promising new treatment option for systemic lupus erythematosus
  273. Meta analysis on the association between FcγRIIa-R/H131 polymorphisms and systemic lupus erythematosus
  274. Anti-neutrophil Cytoplasmic Antibodies in New-onset Systemic Lupus Erythematosus and Lupus Nephritis
  275. Type 17 T-helper cells might be a promising therapeutic target for systemic lupus erythematosus
  276. Reactivation of inactive X chromosome: A potential culprit and therapeutic target for Systemic lupus erythematosus
  277. Clinical and laboratory profiles of systemic lupus erythematosus associated with Sjögren syndrome in China: a study of 542 patients